ALNYLAM PHARMACEUTICALS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31)
ALNYLAM PHARMACEUTICALS, INC. (ALNY) had Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) of 42.38 million shares as of 2011-06-30, per its 10-Q filed 2011-08-03.
Discontinued › Notes
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicAndDiluted · last filed 2011-08-03
- 2011-06-30: Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) 42.38M shares.
- 2010-06-30: Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) 41.99M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) |
|---|---|
| 2011-06-30 | 42.38M shares 10-Q · filed 2011-08-03 |
| 2010-06-30 | 41.99M shares 10-Q · filed 2011-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |